Fairvalue-Calculator Fairvalue-Calculator
EN DE

Trinity Capital Inc (TRIN) Fair Value & Analysis

Financial Services · US · Market cap $1.5B

Price$16.84
Fair Value$17.04
Upside+1.2%
Quality95/100
Evidence: High Range $12.78 – $21.30

Analysis

Trinity Capital Inc (TRIN) currently trades at $16.84, while our model-based Fair Value estimate is $17.04 — implying the stock looks roughly 1.2% undervalued today. We read business quality at 95/100 (high quality), in the Financial Services sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

Trinity Capital Inc. is a business development company specializing in term loans, equipment financing, and private equity-related investments. The firm provides tech lending, equipment financing, life sciences, warehouse lending, and sponsor finance sources. The firm is industry agnostic and invests in growth-stage companies across industries, including aerospace, software, Agricultural Equipment, Alternative Protein, Clean Technology, Energy, Food and Beverage / CPG, Information Technology, Life Sciences, Oil and Gas, Robotics, Semiconductors, Transportation, and consumer and retail. They provide investors with stable and consistent returns through access to the private credit market. Trinity Capital Inc. was founded in 2008 and is based in Phoenix, Arizona, with additional offices in Solana Beach, California and San Diego, California.

Open the full interactive analysis →

Similar stocks

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.